Carr Edward: insider trades.
Carr Edward reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($2.0M), across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 5
- Companies
- 1
- Name as filed
- CARR EDWARD
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | Officer · CHIEF ACCOUNTING OFFICER | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-17 | Dianthus Therapeutics, Inc. /DE/ | M | 20,000 | $17.88 | 20,000 | Form 4 |
| 2026-09-17 | Dianthus Therapeutics, Inc. /DE/ | S | 7,928 | $100.43 | 12,072 | Form 4 |
| 2026-09-17 | Dianthus Therapeutics, Inc. /DE/ | S | 6,771 | $101.37 | 5,301 | Form 4 |
| 2026-09-17 | Dianthus Therapeutics, Inc. /DE/ | S | 3,501 | $102.39 | 1,800 | Form 4 |
| 2026-09-17 | Dianthus Therapeutics, Inc. /DE/ | S | 700 | $104.39 | 0 | Form 4 |
| 2026-09-17 | Dianthus Therapeutics, Inc. /DE/ | S | 1,100 | $103.2 | 700 | Form 4 |
Questions
What stock did Carr Edward buy or sell?
Carr Edward reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($2.0M), across 1 company.
Is Carr Edward the same person as other filers with this name?
This page covers SEC CIK 1273351 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/carr-edward-1273351.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.